The purpose of this study is to determine whether intrapleural treatment with Dornase alfa plus Urokinase improves clinical outcome compared to Urokinase alone in children with complicated parapneumonic effusions
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
94
Intrapleural administration of: * Urokinase 40,000 in 40ml normal saline, twice daily for 4 days * Dornase alfa 2,500 IU in 25ml normal saline, twice daily for 4 days
Intrapleural administration of: * Urokinase 40,000 in 40ml normal saline, twice daily for 4 days * 25ml normal saline, twice daily for 4 days
Ospedali Riuniti di Bergamo
Bergamo, Italy
RECRUITINGAzienda Ospedaliera di Padova
Padua, Italy
RECRUITINGOspedale Bambino Gesu'
Roma, Italy
RECRUITINGDuration of hospital stay
Time frame: From beginning of intrapleural treatment
Need for additional surgical procedures
Time frame: 3 months
Duration of suction applied to chest drain
Time frame: From beginning of intrapleural treatment
Duration of fever
Time frame: From beginning of intrapleural treatment
Duration of intravenous antibiotic treatment
Time frame: From beginning of intrapleural treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.